Related references
Note: Only part of the references are listed.CXCL13 as biomarker for histological involvement in Sjogren's syndrome
Serena Colafrancesco et al.
RHEUMATOLOGY (2020)
SERUM CXCL13 LEVELS ARE ASSOCIATED WITH LYMPHOMA RISK AND LYMPHOMA OCCURRENCE IN PRIMARY SJOGREN'S SYNDROME
Emmanuella Traianos et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
B-cell activity markers are associated with different disease activity domains in primary Sjogren's syndrome
Katherine James et al.
RHEUMATOLOGY (2018)
The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus A STROBE-compliant article
Chenglong Fang et al.
MEDICINE (2017)
Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
Sofia Fragkioudaki et al.
MEDICINE (2016)
CXCL13 is a plasma biomarker of germinal center activity
Colin Havenar-Daughton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients
Aristea Papageorgiou et al.
PLOS ONE (2015)
CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjogren's Syndrome
G. Nocturne et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study
Luca Quartuccio et al.
JOURNAL OF AUTOIMMUNITY (2014)
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
Adrianos Nezos et al.
JOURNAL OF AUTOIMMUNITY (2014)
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands
Luca Quartuccio et al.
RHEUMATOLOGY (2013)
Pathogenesis of Sjogren's syndrome: What we know and what we should learn
Athanasios G. Tzioufas et al.
JOURNAL OF AUTOIMMUNITY (2012)
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome
Elke Theander et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics
Julia Saez de Guinoa et al.
BLOOD (2011)
United Kingdom Primary Sjogren's Syndrome Registry-a united effort to tackle an orphan rheumatic disease
Wan-Fai Ng et al.
RHEUMATOLOGY (2011)
Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjogren's Syndrome
Roser Solans-Laque et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjogren's syndrome
Roy A. Fava et al.
ARTHRITIS RESEARCH & THERAPY (2011)
CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: Association with reactive and malignant areas of lymphoid organization
Francesca Barone et al.
JOURNAL OF IMMUNOLOGY (2008)
Follicular dendritic cell networks of primary follicles and germinal centers: Phenotype and function
Christopher D. C. Allen et al.
SEMINARS IN IMMUNOLOGY (2008)
Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias
Athanasios G. Tzioufas et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2007)
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome
Michele Bombardieri et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas
Andrew P. R. Sutherland et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression
Ata-Ur Rasheed et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors
E. Theander et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
KE Smedby et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Role of chemokines in the development of secondary and tertiary lymphoid tissues
T Cupedo et al.
SEMINARS IN IMMUNOLOGY (2003)
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome
JPA Ioannidis et al.
ARTHRITIS AND RHEUMATISM (2002)
A chemokine-driven positive feedback loop organizes lymphoid follicles
KM Ansel et al.
NATURE (2000)
Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome
FN Skopouli et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis
SA Luther et al.
IMMUNITY (2000)
Share Paper
